Definium Therapeutics, Inc. (DFTX)
38.80
+0.12
(+0.31%)
USD |
NASDAQ |
Sep 18, 16:00
38.67
-0.13
(-0.34%)
After-Hours: 20:00
Definium Therapeutics Cash from Investing (Quarterly) : -315.46M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -315.46M |
| March 31, 2026 | 42.00M |
| December 31, 2025 | 37.53M |
| September 30, 2025 | 16.10M |
| June 30, 2025 | -43.10M |
| March 31, 2025 | -162.46M |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 |
| Date | Value |
|---|---|
| September 30, 2021 | -0.0192M |
| June 30, 2021 | 0.0881M |
| March 31, 2021 | -0.477M |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| August 31, 2019 | -0.046M |
| May 31, 2019 | -0.004M |
| February 28, 2019 | -0.0613M |
| November 30, 2018 | -0.1024M |
| August 31, 2018 | -0.1433M |
| May 31, 2018 | 0.2489M |
| February 28, 2018 | 0.2069M |
| November 30, 2017 | 0.2161M |
| August 31, 2017 | -0.1256M |
| May 31, 2017 | -1.763M |
| February 28, 2017 | -1.320M |
| November 30, 2016 | -0.5583M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Enliven Therapeutics, Inc. | -441.57M |
| Cocrystal Pharma, Inc. | 0.00 |
| CNBX Pharmaceuticals, Inc. | 0.00 |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 54.90M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -52.33M |
| Cash from Financing (Quarterly) | 758.70M |
| Free Cash Flow | -166.74M |
| Free Cash Flow Per Share (Quarterly) | -0.4728 |
| Free Cash Flow to Equity (Quarterly) | -48.03M |
| Free Cash Flow to Firm (Quarterly) | -51.10M |
| Free Cash Flow Yield | -4.25% |